Seasonal Affective Disorder
- David Stephen Klein, MD FACA FACPM

- Feb 28
- 4 min read
When Light Deprivation Becomes a Neuroendocrine Disorder, worse in the Northern Latitudes

Introduction
Seasonal Affective Disorder (SAD) is frequently dismissed as a transient reaction to winter stress or reduced outdoor activity. Clinically, that view is incomplete. SAD represents a predictable, light-driven neuroendocrine disorder with reproducible effects on circadian timing, neurotransmitter balance, hormonal signaling, and inflammatory tone.
For affected patients, symptoms extend well beyond mood. Fatigue, hypersomnia, cognitive slowing, metabolic changes, and reduced resilience to stress are common. The encouraging reality is that SAD is highly identifiable and highly treatable when approached biologically rather than psychologically alone.
What Is Seasonal Affective Disorder?
Seasonal Affective Disorder is defined as a recurrent depressive pattern with a clear seasonal onset and remission, most commonly beginning in late fall or winter and resolving in spring or early summer¹.
While categorized within mood disorders, SAD is best conceptualized as a circadian misalignment syndrome precipitated by reduced light exposure.
Typical features include¹²:
Depressed or flattened mood
Loss of interest or motivation
Hypersomnia and non-restorative sleep
Daytime fatigue and psychomotor slowing
Increased carbohydrate craving and weight gain
Impaired concentration and executive function
The Biology of Light and Mood
(See Figure 1)

Light is the dominant regulator of human circadian biology. Retinal light exposure signals the suprachiasmatic nucleus (SCN), synchronizing sleep–wake cycles, cortisol rhythm, melatonin suppression, and monoamine signaling³.
When daylight exposure decreases:
Circadian phase is delayed
Morning cortisol signaling is blunted
Melatonin secretion becomes prolonged and mistimed⁴
Daytime alertness and mood regulation deteriorate
This is not a subjective response to winter—it is objective circadian dysregulation.
Neurotransmitters, Hormones, and Vitamin D
Serotonin
Seasonal reductions in sunlight are associated with increased serotonin transporter (SERT) activity, effectively lowering synaptic serotonin availability⁵. This mechanism directly links reduced light exposure to depressive symptoms.
Melatonin
Patients with SAD often exhibit extended melatonin secretion into waking hours, contributing to lethargy, sleep inertia, and mood suppression⁴.
Vitamin D
Vitamin D functions as a neuroactive steroid hormone, influencing serotonin synthesis, neuroplasticity, and inflammatory signaling⁶. Wintertime deficiency is common and correlates with depressive severity⁷.
SAD is not merely emotional—it is biochemical, hormonal, and circadian.
Who Is at Risk?
(See Figure 2)

Risk factors include²⁸:
Residence at higher latitudes
Female sex
Family history of mood disorders
Vitamin D deficiency
Thyroid dysfunction
Insulin resistance or metabolic syndrome
Chronic circadian disruption
Importantly, SAD often coexists with subclinical endocrine or metabolic abnormalities, which are frequently overlooked in symptom-only evaluations.
Evidence-Based Treatment Strategies
(See Figure 3)

Bright Light Therapy (First-Line)
Morning exposure to 10,000 lux full-spectrum light for 20–30 minutes remains the most effective first-line treatment³⁹. Proper timing—early morning—is critical for circadian realignment.
Vitamin D Repletion
Correction of deficiency, typically targeting serum 25-OH vitamin D levels of 40–60 ng/mL, improves depressive symptoms in deficient patients⁶⁷. Dosing should be individualized and monitored. Some patients feel best when the levels approach 100 or so.
Cognitive Behavioral Therapy for SAD (CBT-SAD)
CBT-SAD demonstrates efficacy comparable to light therapy, with lower recurrence rates across subsequent seasons¹⁰.
Pharmacologic Therapy
SSRIs and SNRIs may be helpful in moderate to severe cases but should be considered adjunctive, particularly when circadian and endocrine drivers remain uncorrected¹¹.
Why SAD Is Commonly Missed
Patients are often reassured that symptoms reflect:
Normal winter stress
Aging
Burnout
Lifestyle factors
Without attention to seasonal patterning and biologic context, the diagnosis is delayed and treatment becomes fragmented.
Bottom Line
Seasonal Affective Disorder is a predictable, biologically mediated condition driven by light deprivation and circadian disruption. When addressed with targeted, physiology-based interventions, outcomes are excellent. The goal is not merely mood improvement, but restoration of normal neuroendocrine alignment.
Become a Patient
If fatigue, low mood, sleep disruption, or cognitive slowing recur each winter, a structured evaluation can determine whether Seasonal Affective Disorder—or a related endocrine contributor—is present.Become a Patient →
References
Rosenthal NE, Sack DA, Gillin JC, et al. Seasonal affective disorder: A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72-80.https://pubmed.ncbi.nlm.nih.gov/6581756/
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: APA; 2022.
Lewy AJ, Sack RL, Miller LS, Hoban TM. Antidepressant and circadian phase-shifting effects of light. Am J Psychiatry. 1987;144(6):741-747.https://pubmed.ncbi.nlm.nih.gov/3578559/
Wehr TA, Duncan WC Jr, Sher L, et al. A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry. 2001;58(12):1108-1114.https://pubmed.ncbi.nlm.nih.gov/11735841/
Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet. 2002;360(9348):1840-1842.https://pubmed.ncbi.nlm.nih.gov/12480356/
Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Prog Neurobiol. 2013;106-107:47-59.https://pubmed.ncbi.nlm.nih.gov/23305840/
Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: Systematic review and meta-analysis. Br J Psychiatry. 2013;202(2):100-107.https://pubmed.ncbi.nlm.nih.gov/23377209/
Magnusson A, Partonen T. The diagnosis, symptomatology, and epidemiology of seasonal affective disorder. CNS Spectr. 2005;10(8):625-634.https://pubmed.ncbi.nlm.nih.gov/16041296/
Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: A review and meta-analysis of the evidence. Am J Psychiatry. 2005;162(4):656-662.https://pubmed.ncbi.nlm.nih.gov/15800134/
Rohan KJ, Meyerhoff J, Ho SY, et al. Outcomes one and two winters following cognitive-behavioral therapy or light therapy for seasonal affective disorder. Am J Psychiatry. 2015;172(9):862-869.https://pubmed.ncbi.nlm.nih.gov/26085095/
Lam RW, Levitt AJ, Levitan RD, et al. The CAN-SAD study: A randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry. 2006;163(5):805-812.https://pubmed.ncbi.nlm.nih.gov/16648321/
The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances.
1917 Boothe Circle, Suite 171
Longwood, Florida 32750
Tel: 407-679-3337
Fax: 407-678-7246







.webp)